FIELD: chemistry.
SUBSTANCE: group of inventions relates to organic chemistry and includes pentacyclic derivatives specified in the claim, a pharmaceutical composition containing them, a therapeutic agent, a method of treating cognitive dysfunction and use thereof.
EFFECT: novel pentacyclic derivatives having an activating effect on cholinergic neurons and used to treat cognitive dysfunction.
8 cl, 2 dwg, 2 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PENTACYCLIC COMPOUND | 2018 |
|
RU2754557C1 |
| PENTACYCLIC COMPOUND SALT AND CRYSTAL THEREOF | 2020 |
|
RU2820938C2 |
| CONDENSED HETEROCYCLIC NITROGEN COMPOUNDS AND USING THEM AS INHIBITORS OF AMYLOID BETA PRODUCTION | 2010 |
|
RU2515976C2 |
| SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
| NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
| TETRAHYDROIMIDAZO[1,5-D][1,4]OXAZEPINE DERIVATIVE | 2014 |
|
RU2659219C2 |
| PIRAZOLOQINOLINE DERIVATIVE | 2012 |
|
RU2605096C2 |
| HYDROXYPURINE COMPOUNDS AND WAYS OF THEIR USE | 2015 |
|
RU2673458C1 |
| MORPHOLINE TYPE CINNAMIDE DERIVATIVE | 2006 |
|
RU2381225C1 |
| DERIVATIVES OF ARYL-5-THIO-β-D-GLYCOPYRANOSIDE AND THERAPEUTIC AGENT COMPRISING THEREOF USED IN DIABETES MELLITUS | 2003 |
|
RU2322449C2 |
